CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Net revenues	$ 10,659,708	$ 7,642,474	$ 32,233,441	$ 23,402,254
Costs and expenses
Cost of services	8,463,541	6,090,345	24,295,598	15,511,829
General and administrative	3,510,045	2,889,598	11,187,891	8,350,837
Depreciation and amortization	145,594	194,060	287,029	399,240
Total costs and expenses	12,119,180	9,174,003	35,770,518	24,261,906
Loss from operations	(1,459,472)	(1,531,529)	(3,537,077)	(859,652)
Other (expense) income
Interest expense	(100,983)	(362,935)	(530,203)	(969,060)
Gain on change in fair value of warrant and conversion feature liabilities, net	430,396	358,433	313,530	480,568
Loss on debt extinguishment	(266,364)	0	(266,364)	0
Other	(100,344)	112,648	(94,431)	51,736
Total other (expense) income	(37,295)	108,146	(577,468)	(436,756)
Loss before provision for income taxes	(1,496,767)	(1,423,383)	(4,114,545)	(1,296,408)
Income tax (benefit) provision	36,196	(31,944)	(57,251)	66,647
Net loss	(1,532,963)	(1,391,439)	(4,057,294)	(1,363,055)
Net income attributable to non-controlling interest	(152,648)	(300,144)	(642,050)	(629,959)
Net loss attributable to Apollo Medical Holdings, Inc.	(1,685,611)	(1,691,583)	(4,699,344)	(1,993,014)
Other comprehensive loss:
Unrealized loss on change in value of marketable securities	0	(33,088)	0	0
Comprehensive loss	$ (1,685,611)	$ (1,724,671)	$ (4,699,344)	$ (1,993,014)
NET LOSS PER SHARE:
BASIC	$ (0.31)	$ (0.35)	$ (0.93)	$ (0.41)
DILUTED	$ (0.31)	$ (0.35)	$ (0.93)	$ (0.41)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING:
BASIC	5,365,563	4,875,955	5,031,389	4,900,909
DILUTED	5,365,563	4,875,955	5,031,389	4,900,909